|
|
Bone Marrow Human Tissue Microarray, 24 Cases and 48 Cores
|
|
Item Number: IBM481
|
Arrayit Bone Marrow Human Tissue Microarray, 24 Cases and 48 Cores is a normal bone marrow tissue array, 24 cases/48 cores. Arrayit offers an extensive line of more than 1,000 high quality tissue microarrays for basic and cancer research, life sciences, clinical and histological applications. Tissue microarrays (TMAs) are glass slides (1 x 25 x 76 mm) containing thin section miniaturized arrays of paraffin-embedded cylindrical tissue cores. Arrayit tissue microarrays are manufactured using more than 50 different human tissues obtained from surgical pathology, autopsy and other sources, embedded in paraffin to create donors blocks. A tissue microarrayer punches miniature cylindrical tissue cores from the donor blocks and prints them in a defined pattern at high density into recipient blocks such that dozens or hundreds of tissue cores can be printed into the recipient blocks. A microtome is used to cut thin sections from the recipient blocks and the tissue sections are transferred onto glass slides to complete the tissue microarray manufacturing process. TMA slides are analyzed using powerful techniques including histochemical staining, immunohistochemical staining, immunofluorescent staining and in situ hybridization with DNA or mRNA probes. Because multiple patient samples are analyzed in a massively parallel format, TMAs greatly reduce experimental variability and technical artifacts compared to traditional techniques. Clinical cancer patient cohorts and corresponding tissue microarray sets have been used to study diagnostic, prognostic and treatment predictive cancer biomarkers in most forms of cancer including lung, breast, colorectal and renal cell cancer. Tissue microarrays and immunohistochemistry have been combined in large scale efforts to create a protein expression map on a proteomic scale. Arrayit Bone Marrow Human Tissue Microarray, 24 Cases and 48 Cores ships as 1 tissue microarray slide per order.
Arrayit offers more than 1,000 high quality tissue
microarrays for basic and cancer research, life sciences, clinical and
histological applications. Tissue microarrays (TMAs) are glass slides (1 x 25 x
76 mm) containing thin section miniaturized arrays of paraffin-embedded
cylindrical tissue cores. TMA slides are analyzed using powerful techniques
including histochemical staining, immunohistochemical staining,
immunofluorescent staining and in situ
hybridization with DNA or mRNA probes. Because multiple patient tissue samples
are analyzed in a miniaturized and massively parallel format, TMAs greatly
reduce experimental variability and technical artifacts and speed histological
analysis compared to traditional techniques.
Technical
Support
Please contact us by email arrayit@arrayit.com for worldwide technical
support.
Scientific
Publications
Click here and here for
Arrayit tissue microarray scientific publications.
Ordering
Information
|
No.
|
Catalog ID
|
Rows
|
Columns
|
Cases
|
Cores
|
Category
|
Description
|
|
1
|
DAG241
|
3
|
8
|
6
|
24
|
Adrenal Gland
|
Adrenal gland tumor with adrenal gland tissue test array, 6
cases/24 cores
|
|
2
|
EAG1601
|
10
|
16
|
80
|
160
|
Adrenal Gland
|
Adrenal gland tumor tissue array, including pathology grade, TNM
and clinical stage, 80 cases/160 cores
|
|
3
|
EAG-2081a
|
12
|
16
|
96
|
192
|
Adrenal Gland
|
Adrenal gland disease spectrum (adrenal gland cancer
progression) tissue array (2017 WHO classification), including TNM and
clinical stage (AJCC 7th edition), 96 cases/192 cores, replacing AD2081
|
|
4
|
EAG481
|
6
|
8
|
24
|
48
|
Adrenal Gland
|
Adrenal gland tumor tissue array with normal tissue, including
pathology grade, TNM and clinical stage, 24 cases/48 cores
|
|
5
|
EAG721
|
8
|
9
|
72
|
72
|
Adrenal Gland
|
Adrenal gland tumor tissue array, including pathology grade, TNM
and clinical stage, 72 cases/72 cores
|
|
6
|
DAP1001
|
10
|
10
|
50
|
100
|
Appendix
|
Vermiform appendix disease spectrum (vermiform appendix cancer
progression) tissue array, including pathology grade, 50 cases/100 cores
|
|
7
|
DAP241
|
3
|
8
|
6
|
24
|
Appendix
|
Appendix cancer with appendix tissue test array, including
pathology grade, TNM and clinical stage, 6 cases/24 cores
|
|
8
|
BL2081c
|
12
|
16
|
191
|
192
|
Bladder
|
Bladder cancer with bladder tissue array, including pathology
grade, TNM and clinical stage, 191 cases/192 cores, replacing BL2081b
|
|
9
|
BL241a
|
4
|
6
|
10
|
24
|
Bladder
|
Bladder cancer tissue array with matched cancer adjacent tissue,
including pathology grade, TNM and clinical stage, 10 cases/24 cores,
replacing BL241
|
|
10
|
BL482
|
6
|
8
|
48
|
48
|
Bladder
|
Bladder cancer tissue array, including pathology grade, TNM and
clinical stage, 48 cases/48 cores
|
|
11
|
BL601c
|
6
|
10
|
60
|
60
|
Bladder
|
Bladder cancer (stage III-IV) tissue array, including TNM and
clinical stage, 60 cases/60 cores, replacing BL601b
|
|
12
|
BL805a
|
8
|
10
|
80
|
80
|
Bladder
|
Mid-advanced stage bladder cancer tissue array, with metastasis
tissue, including TNM and pathology grade, 80 cases/80 cores, replacing BL805
|
|
13
|
BLA501
|
6
|
9
|
50
|
50
|
Bladder
|
Bladder cancer with bladder tissue array (2016 WHO
classification), including pathology grade, TNM and clinical stage (AJCC 7th edition),
50 cases/50 cores
|
|
14
|
UBD1001
|
10
|
10
|
25
|
100
|
Bladder
|
Bladder tumor tissue array, including TNM and clinical stage, 25
cases/100 cores
|
|
15
|
UBD1002a
|
10
|
10
|
50
|
100
|
Bladder
|
Bladder cancer array with cancer adjacent tissue, including TNM
and pathology grade, 50 cases/100 cores
|
|
16
|
UBD1003
|
10
|
10
|
50
|
100
|
Bladder
|
Bladder cancer tissue array with bladder tissue, including TNM
and clinical stage, 50 cases/100 cores
|
|
17
|
UBD1501
|
10
|
15
|
75
|
150
|
Bladder
|
Bladder cancer tissue array, including pathology grade, TNM and
clinical stage, 75 cases/150 cores
|
|
18
|
UBD1921
|
12
|
16
|
96
|
192
|
Bladder
|
Middle-advanced stage bladder cancer tissue array, including
pathology grade, TNM and clinical stage, 96 cases/192 cores
|
|
19
|
UBD241
|
3
|
8
|
6
|
24
|
Bladder
|
Bladder cancer with bladder tissue test array, including
pathology grade, TNM and clinical stage, 6 cases/24 cores, replacing T121
|
|
20
|
UBD242
|
3
|
8
|
6
|
24
|
Bladder
|
Bladder cancer with bladder tissue test array, including
pathology grade, TNM and clinical stage, 2 serial sections, 6 cases/24 cores
|
|
21
|
UBD243
|
3
|
8
|
12
|
24
|
Bladder
|
Bladder cancer tissue array with normal bladder tissue,
including pathology grade, TNM and clinical stage, 12 cases/24 cores,
replacing T124a
|
|
22
|
UBD243a
|
4
|
6
|
12
|
24
|
Bladder
|
Bladder cancer tissue array with cancer adjacent tissue,
including TNM and clinical stage, 12 cases/24 cores, replacing BL243
|
|
23
|
UBD244
|
4
|
6
|
6
|
24
|
Bladder
|
Bladder cancer tissue array, including pathology grade, TNM and
clinical stage, 6 cases/24 cores
|
|
24
|
UBD541
|
7
|
8
|
27
|
54
|
Bladder
|
Different stages bladder cancer tissue array with matched
adjacent normal or cancer adjacent tissue, including pathology grade, TNM and
clinical stage, 27 cases/54 cores
|
|
25
|
UBD601b
|
6
|
10
|
60
|
60
|
Bladder
|
Bladder cancer (stage III-IV) tissue array, including TNM and
clinical stage, 60 cases/60 cores, replacing BL601a
|
|
26
|
UBD632
|
7
|
9
|
63
|
63
|
Bladder
|
Bladder cancer array with bladder tissue, including TNM and
clinical stage, 63 cases/63 cores
|
|
27
|
UBD641
|
8
|
8
|
64
|
64
|
Bladder
|
Urothelial carcinoma tissue array, including pathology grade,
TNM and clinical stage, 64 cases/64 cores
|
|
28
|
UBD721
|
8
|
9
|
24
|
72
|
Bladder
|
Bladder cancer tissue array with adjacent normal tissue,
including TNM and clinical stage, 24 cases/72 cores
|
|
29
|
UBD802
|
8
|
10
|
78
|
80
|
Bladder
|
Bladder cancer tissue array with bladder tissue, including TNM
and clinical stage, 78 cases/80 cores
|
|
30
|
UBD803
|
8
|
10
|
40
|
80
|
Bladder
|
Bladder cancer tissue array with normal tissue, including TNM
and clinical stage, 40 cases/80 cores
|
|
31
|
UBD811
|
9
|
9
|
81
|
81
|
Bladder
|
Bladder cancer tissue array with bladder tissue, including TNM
and pathology grade, 81 cases/81 cores
|
|
32
|
UBD812
|
9
|
9
|
27
|
81
|
Bladder
|
Bladder cancer tissue array with bladder tissue, including
pathology grade, TNM and clinical stage, 27 cases/81 cores
|
|
33
|
UBD901
|
9
|
10
|
90
|
90
|
Bladder
|
Different stage of bladder cancer tissue array, including TNM
and clinical stage, 90 cases/90 cores
|
|
34
|
UBD902
|
9
|
10
|
90
|
90
|
Bladder
|
Multiple of bladder cancer tissue array with bladder tissue,
including pathology grade, TNM and clinical stage, 90 cases/90 cores
|
|
35
|
DPA2081d
|
12
|
16
|
96
|
192
|
Bladder
|
Pancreas disease spectrum (pancreatic cancer progression) with
pancreas tissue array, including pathology grade, TNM and clinical stage, 96
cases/192 cores, replacing PA2081c
|
|
36
|
UBD2082b
|
13
|
16
|
208
|
208
|
Bladder
|
Bladder cancer tissue array, including TNM and clinical stage,
208 cases/208 cores, replacing BL2082a
|
|
37
|
UBD208a
|
12
|
16
|
64
|
192
|
Bladder
|
Multiple bladder cancer with bladder tissue array, with
metastatic carcinoma, including pathology grade, TNM and clinical stage, 64
cases/192 cores, replacing BL208
|
|
38
|
UBD601
|
6
|
10
|
60
|
60
|
Bladder
|
Bladder cancer (stage III-IV) tissue array, including pathology
grade, TNM and clinical stage, 60 cases/60 cores
|
|
39
|
UBD806c
|
8
|
10
|
66
|
80
|
Bladder
|
Bladder cancer and bladder tissue array, including pathology
grade, TNM and clinical stage, 66 cases/80 cores, replacing BL806b
|
|
40
|
S-OSCS1602M
|
8
|
10
|
80
|
80
|
Bone
|
Combined microarray for osteosarcoma and chondrosarcoma with
survival data, including TNM, survival status and clinical stage, 80
cases/80 cores
|
|
41
|
BON501
|
6
|
9
|
50
|
50
|
Bone Cartilage
|
Osteosarcoma tissue with normal tissue array, including TNM and
clinical stage, 50 cases/50 cores
|
|
42
|
LBN241
|
3
|
8
|
6
|
24
|
Bone Cartilage
|
Bone and cartilage tumor with normal tissue array, including TNM
and clinical stage, 6 cases/24 cores
|
|
43
|
LBN244f
|
3
|
8
|
12
|
24
|
Bone Cartilage
|
Normal bone tissue array with osteosarcoma tissue, including TNM
and clinical stage, 12 cases/24 cores
|
|
44
|
LBN246
|
4
|
6
|
12
|
24
|
Bone Cartilage
|
Bone, cartilage tumor with adjacent normal tissue array, including
TNM and clinical stage, 12 cases/24 cores
|
|
45
|
LBN247
|
3
|
8
|
6
|
24
|
Bone Cartilage
|
Bone tumor and cartilage tumor tissue array, with bone tissue,
including TNM and clinical stage, 6 cases/24 cores
|
|
46
|
LBN262a
|
3
|
8
|
12
|
24
|
Bone Cartilage
|
Bone tumor test tissue array with normal tissue as control,
including TNM, clinical stage, 12 cases/24 cores, replacing T262
|
|
47
|
LBN481
|
6
|
8
|
48
|
48
|
Bone Cartilage
|
Bone and cartilage tumor tissue array with adjacent normal bone
tissue, including TNM and clinical stage, 48 cores/48 cases
|
|
48
|
LBN802
|
8
|
10
|
80
|
80
|
Bone Cartilage
|
Osteosarcoma and chondrosarcoma tissue array, including TNM and
clinical stage, 80 cases/80 cores
|
|
49
|
LBN805
|
8
|
10
|
80
|
80
|
Bone Cartilage
|
Chondrosarcoma tissue array, 80 cases/80 cores
|
|
50
|
LBN811
|
9
|
9
|
27
|
81
|
Bone Cartilage
|
Chondrosarcoma tissue array, 27 cases/81 cores
|
|
51
|
LBO804e
|
8
|
10
|
40
|
80
|
Bone Cartilage
|
Osteosarcoma tissue array, including TNM and clinical stage, 40
cases/80 cores
|
|
52
|
OS802e
|
8
|
10
|
80
|
80
|
Bone Cartilage
|
Osteosarcoma and chondrosarcoma tissue array, including TNM and
clinical stage, 80 cases/80 cores, replacing OS802c
|
|
53
|
BO481b
|
6
|
8
|
48
|
48
|
Bone Cartilage
|
Bone and cartilage tumor with bone tissue array, including TNM
and clinical stage, 48 cores/48 cases, replacing BO481a
|
|
54
|
BCC26012
|
4
|
6
|
24
|
24
|
Bone Marrow
|
Osteochondroma with adjacent normal tissue array, 24 cases/24
cores
|
|
55
|
BM241a
|
4
|
6
|
12
|
24
|
Bone Marrow
|
Bone marrow tissue array, 12 cases/24 cores, replacing BM241
|
|
56
|
BN29011b
|
6
|
10
|
33
|
60
|
Bone Marrow
|
Bone marrow, spleen and lymph node tissue array, 33 cases/60
cores, replacing BN29011a
|
|
57
|
BOM501
|
6
|
9
|
50
|
50
|
Bone Marrow
|
Normal bone marrow tissue array, 50 cases/50 cores
|
|
58
|
IBM241
|
3
|
8
|
6
|
24
|
Bone Marrow
|
Bone marrow tumor and normal tissue array, including TNM and
pathology grade, 6 cases/24 cores, replacing T293
|
|
59
|
IBM291c
|
3
|
8
|
6
|
24
|
Bone Marrow
|
Myeloma tissue array with normal bone marrow tissue, 6 cases/24
cores, replacing T291b
|
|
60
|
IBM291d
|
3
|
8
|
6
|
24
|
Bone Marrow
|
Myeloma tissue array with bone marrow tissue, 6 cases/24 cores
|
|
61
|
IBM481
|
7
|
8
|
24
|
48
|
Bone Marrow
|
Normal bone marrow tissue array, 24 cases/48 cores
|
|
62
|
LBM481a
|
7
|
8
|
24
|
48
|
Bone Marrow
|
Normal bone marrow tissue array, 24 cases/48 cores
|
|
63
|
LBN245
|
4
|
6
|
12
|
24
|
Bone Marrow
|
Bone marrow tissue array, 12 cases/24 cores
|
|
64
|
LBN483c
|
6
|
8
|
24
|
48
|
Bone Marrow
|
Bone tumor and adjacent normal tissue array, including TNM and
clinical stage, 24 cases/48 cores, replacing BM483b
|
|
65
|
LBN483d
|
6
|
8
|
24
|
48
|
Bone Marrow
|
Bone tumor and adjacent normal tissue array, including TNM and
clinical stage, 24 cases/48 cores
|
|
66
|
LBN601
|
6
|
10
|
30
|
60
|
Bone Marrow
|
Bone marrow, spleen and lymph node tissue array, 30 cases/60
cores
|
|
67
|
GL1001b
|
10
|
10
|
100
|
100
|
Brain
|
Brain cancer and brain tissue array as control, including
pathology grade, 100 cases/100 cores, replacing GL1001a
|
|
68
|
GL151a
|
3
|
5
|
15
|
15
|
Brain
|
Ependymoma tissue array, including pathology grade, 15 cases/15
cores, replacing GL151
|
|
69
|
GL241d
|
4
|
6
|
12
|
24
|
Brain
|
Brain tumor with brain tissue array, including pathology grade,
12 cases/24 cores, replacing GL241c
|
|
70
|
GL722a
|
8
|
9
|
24
|
72
|
Brain
|
Brain glioma and normal tissue array, including pathology grade,
24 cases/72 cores, replacing GL722
|
|
71
|
GL804a
|
8
|
10
|
40
|
80
|
Brain
|
Brain tumor and brain tissue array, including pathology grade,
40 cases/80 cores
|
|
72
|
MG801a
|
8
|
10
|
80
|
80
|
Brain
|
Meningioma of central nerve tissue array, 80 cases/80 cores,
replacing MG801
|
|
73
|
NCT1002
|
10
|
10
|
50
|
100
|
Brain
|
Brain tumor and normal tissue array, 50 cases/100 cores
|
|
74
|
NCT175b
|
3
|
8
|
12
|
24
|
Brain
|
Brain tumor tissue array with brain tissue, including pathology
grade, 12 cases/24 cores, replacing T175a
|
|
75
|
NCT1921
|
12
|
16
|
96
|
192
|
Brain
|
Brain tumor tissue array, including pathology grade, 96
cases/192 cores
|
|
76
|
NCT1921a
|
12
|
16
|
96
|
192
|
Brain
|
Brain tumor tissue microarray, containing 96 cases of tumor (47
astrocytoma, 41 glioblastoma, 3 ependymoma, 2 each of ganglion glioma and
gliosarcoma, 1 medulloblastoma), duplicate cores per case, divided into two
identical 96 core arrays, suitable for therapeutic antibody screening
|
|
77
|
NCT2083b
|
13
|
16
|
208
|
208
|
Brain
|
Brain tumor tissue array, including pathology grade, 208
cases/208 cores, replacing GL2083a
|
|
78
|
NCT241c
|
4
|
6
|
12
|
24
|
Brain
|
Brain tumor with brain tissue array, including pathology grade,
12 cases/24 cores, replacing GL241b
|
|
79
|
NCT242
|
4
|
12
|
24
|
48
|
Brain
|
Brain tumor tissue array with normal tissue, including pathology
grade, 2 serial sections, 24 cases/48 cores
|
|
80
|
NCT243
|
4
|
6
|
6
|
24
|
Brain
|
Brain tumor tissue array, including pathology grade, 6 cases/24
cores
|
|
81
|
NCT481
|
6
|
8
|
48
|
48
|
Brain
|
Brain tumor tissue array, including pathology grade, 48 cases/48
cores
|
|
82
|
NCT482
|
6
|
8
|
48
|
48
|
Brain
|
Brain tumor tissue array with normal tissue, including pathology
grade, 48 cases/48 cores
|
|
83
|
NCT631
|
7
|
9
|
63
|
63
|
Brain
|
Brain tumor tissue array, including pathology grade, 63 cases/63
cores
|
|
84
|
NCT632
|
7
|
9
|
63
|
63
|
Brain
|
Brain tumor with cancer adjacent brain tissue array, including
pathology grade, 63 cases/63 cores
|
|
85
|
NCT721
|
8
|
9
|
24
|
72
|
Brain
|
Brain tumor with brain tissue array, including pathology grade,
24 cases/72 cores
|
|
86
|
NCT722b
|
8
|
9
|
24
|
72
|
Brain
|
Brain glioma with normal tissue array, including pathology
grade, 24 cases/72 cores
|
|
87
|
NCT741
|
8
|
10
|
26
|
74
|
Brain
|
Normal brain tissue array, 26 cases/74 cores
|
|
88
|
NCT801
|
8
|
10
|
79
|
80
|
Brain
|
Brain disease spectrum (brain cancer progression) tissue array,
including pathology grade, TNM and clinical stage, 79 cases/80 cores
|
|
89
|
NCT802
|
8
|
10
|
40
|
80
|
Brain
|
Brain tumor tissue array, 40 cases/80 cores
|
|
90
|
NCT805
|
8
|
10
|
40
|
80
|
Brain
|
Brain glioblastoma tissue array with normal tissue, including
pathology grade, 40 cases/80 cores
|
|
91
|
NCT808
|
8
|
10
|
35
|
80
|
Brain
|
Brain tumor tissue array with matched cancer adjacent or
adjacent normal tissue, including pathology grade, 35 cases/80 cores
|
|
92
|
NCT811
|
8
|
10
|
27
|
81
|
Brain
|
Brain tumor and normal tissue array, including pathology grade,
27 cases/81 cores
|
|
93
|
NCT861
|
9
|
10
|
43
|
86
|
Brain
|
Brain metastatic carcinoma tissue array, including pathology
grade, 43 cases/86 cores
|
|
94
|
NCT961
|
8
|
12
|
96
|
96
|
Brain
|
Multiple types brain tumor tissue array, including pathology
grade, 96 cases/96 cores
|
|
95
|
NGL-241b
|
4
|
6
|
24
|
24
|
Brain
|
Normal cerebrum tissue array, 24 cases/24 cores, replacing
GLN241
|
|
96
|
RAT301
|
5
|
6
|
30
|
30
|
Brain
|
Rat brain tissue array, 30 cases/30 cores
|
|
97
|
RAT301a
|
5
|
6
|
30
|
30
|
Brain
|
Rat brain tissue array, 30 cases/30 cores, replacing RAT301
|
|
98
|
SSO808
|
6
|
10
|
30
|
60
|
Brain
|
Schwannoma (neurilemmoma or neurinoma) of central nerve tissue
array, 30 cases/60 cores
|
|
99
|
YNB642b
|
7
|
10
|
32
|
64
|
Brain
|
Neuroblastoma and peripheral nerve tissue array, including TNM
and INSS stage, 32 cases/64 cores, replacing NB642a
|
|
100
|
YNB642c
|
7
|
10
|
32
|
64
|
Brain
|
Neuroblastoma and peripheral nerve tissue array, including TNM
and clinical stage, 32 cases/64 cores, replacing NB642a
|
|
101
|
B-Her
|
1
|
5
|
5
|
5
|
Breast
|
Breast cancer tissue array, including pathology grade, TNM,
clinical stage and Her-2 marker, 5 cases/5 cores
|
|
102
|
BR1003c
|
10
|
11
|
47
|
101
|
Breast
|
Breast disease spectrum tissue array, including pathology grade,
TNM and clinical stage, 47 cases/101 cores, replacing BR1003b
|
|
103
|
BR1006b
|
10
|
10
|
50
|
100
|
Breast
|
Breast cancer tissue array, including pathology grade, TNM and
clinical stage, 50 cases/100 cores, replacing BR1006a
|
|
104
|
BR1008a
|
10
|
10
|
100
|
100
|
Breast
|
Breast cancer, lymph node metastatic carcinoma and adjacent
normal tissue array, including pathology grade, TNM and clinical stage, 100
cases/100 cores, replacing BR1008
|
|
105
|
BR1081
|
11
|
10
|
54
|
108
|
Breast
|
Breast cancer tissue array, including pathology grade, TNM and
clinical stage, 54 cases/108 cores
|
|
106
|
BR1201b
|
10
|
12
|
60
|
120
|
Breast
|
Breast cancer tissue array (most of triple negative), including
pathology grade, TNM, clinical stage , 60 cases/120 cores, replacing BR1201a
|
|
107
|
BR1202b
|
10
|
12
|
60
|
120
|
Breast
|
Breast cancer tissue array (most of triple negative), including
pathology grade, TNM and clinical stage, 60 cases/120 cores, replacing
BR1202a
|
|
108
|
BR1321
|
12
|
11
|
120
|
132
|
Breast
|
Breast cancer tissue array with lymph node positive and
negative, with cancer adjacent tissue, including pathology grade, TNM and
clinical stage, 120 cases/ 132 cores
|
|
109
|
BR1504c
|
10
|
15
|
75
|
150
|
Breast
|
Breast cancer with breast tissue array, including pathology
grade, TNM and clinical stage, 75 cases/150 cores, replacing BR1504b
|
|
110
|
BR1505f
|
10
|
15
|
75
|
150
|
Breast
|
Breast cancer tissue array, including pathology grade, TNM and
clinical stage, 75 cases/150 cores, replacing BR1505e
|
|
111
|
BR1509a
|
10
|
15
|
50
|
150
|
Breast
|
Breast cancer tissue array (most of triple negative), including
pathology grade, TNM, clinical stage, 50 cases/150 cores
|
|
112
|
BR1510
|
10
|
15
|
50
|
150
|
Breast
|
Breast cancer tissue array (most of Her-2 subtype), including
molecular typing, pathology grade, TNM and clinical stage, 50 cases/150 cores
|
|
113
|
BR201
|
4
|
5
|
20
|
20
|
Breast
|
Breast disease spectrum tissue array, including pathology grade,
TNM and clinical stage, 20 cases/20 cores
|
|
114
|
BR20824
|
13
|
16
|
104
|
208
|
Breast
|
Breast tumor tissue array (18 of 25), including pathology grade,
TNM, clinical stage,104 cases/208 cores
|
|
115
|
BR20825
|
13
|
16
|
104
|
208
|
Breast
|
Breast tumor survey tissue array (19 of 25), including pathology
grade, TNM, clinical stage, 104 cases/208 cores
|
|
116
|
BR20828
|
13
|
16
|
104
|
208
|
Breast
|
Breast cancer survey tissue array (22 of 25), including
pathology grade, TNM and clinical stage, 104 cases/208 cores
|
|
117
|
BR20830
|
13
|
16
|
104
|
208
|
Breast
|
Breast tumor survey tissue array (24 of 25), including pathology
grade, TNM and clinical stage, 104 cases/208 cores
|
|
118
|
BR20831
|
13
|
16
|
104
|
208
|
Breast
|
Breast cancer survey tissue array (25 of 25), including
pathology grade, TNM and clinical stage, 104 cases/208 cores
|
|
119
|
BR20832
|
13
|
16
|
208
|
208
|
Breast
|
Breast tumor survey tissue array (1 of 5), with adjacent normal
tissue, including pathology grade, TNM and clinical stage, 208 cases/208
cores
|
|
120
|
BR20833
|
13
|
16
|
208
|
208
|
Breast
|
Breast tumor survey tissue array (2 of 5), with adjacent normal
tissue, including pathology grade, TNM and clinical stage, 208 cases/208
cores
|
|
121
|
BR20834
|
13
|
16
|
208
|
208
|
Breast
|
Breast tumor survey tissue array (3 of 5), with adjacent normal
tissue, including pathology grade, TNM and clinical stage, 208 cases/208
cores
|
|
122
|
BR20835
|
13
|
16
|
208
|
208
|
Breast
|
Breast tumor survey tissue array (4 of 5), with adjacent normal
tissue, including pathology grade, TNM and clinical stage, 208 cases/208
cores
|
|
123
|
BR20836
|
13
|
16
|
208
|
208
|
Breast
|
Breast cancer survey tissue array (5 of 5), including TNM,
clinical stage and pathology grade, 208 cases/208 cores
|
|
124
|
BR20838
|
13
|
16
|
118
|
208
|
Breast
|
Multiple organs tumor tissue array, including pathology grade,
TNM, clinical stage 118 cases/208 cores
|
|
125
|
BR2085c
|
13
|
16
|
188
|
208
|
Breast
|
Breast cancer with breast tissue array, including pathology
grade, TNM and clinical stage, 188 cases/208 cores, replacing BR2085b
|
|
126
|
BR248a
|
4
|
6
|
24
|
24
|
Breast
|
Breast cancer tissue array with normal tissue, including
pathology grade, TNM and clinical stage, 24 cases/24 cores, replacing BR248
|
|
127
|
BR251d
|
3
|
8
|
6
|
24
|
Breast
|
Breast cancer with matched breast tissue array, including
pathology grade, TNM and clinical stage, 6 cases/24 cores, replacing BR251c
|
|
128
|
BR401
|
5
|
8
|
20
|
40
|
Breast
|
Breast mastitis tissue array, 20 cases/40 cores
|
|
129
|
BR402
|
5
|
8
|
20
|
40
|
Breast
|
Breast mastitis tissue array, 20 cases/40 cores
|
|
130
|
BR484b
|
6
|
8
|
48
|
48
|
Breast
|
Breast cancer tissue array, including pathology grade, TNM and
clinical stage, 48 cases/48 cores, replacing BR484a
|
|
131
|
BR485
|
6
|
16
|
48
|
96
|
Breast
|
Breast cancer and normal tissue array, including pathology
grade, TNM and clinical stage, 2 serial sections, 48 cases/96 cores
|
|
132
|
BR601a
|
6
|
10
|
30
|
60
|
Breast
|
Breast fibroadenoma tissue array, 30 cases/ 60 cores, replacing
BR601
|
|
133
|
BR641
|
8
|
8
|
64
|
64
|
Breast
|
Breast cancer tissue array, including pathology grade, TNM and
clinical stage, 64 cases/ 64 cores
|
|
134
|
BR727
|
8
|
9
|
64
|
64
|
Breast
|
Breast cancer tissue array, including pathology grade, TNM and
clinical stage, 24 cases/72 cores
|
|
135
|
BR728
|
8
|
9
|
24
|
72
|
Breast
|
Breast cancer tissue array, including pathology grade, TNM and
clinical stage, 24 cases/72 cores, replacing BC08015
|
|
136
|
BR8010
|
8
|
10
|
71
|
80
|
Breast
|
Breast fibroadenoma, breast tissue and breast cancer array,
including pathology grade, TNM and clinical stage, 71 cases/80 cores
|
|
137
|
BR8017
|
8
|
10
|
80
|
80
|
Breast
|
Middle-advanced stage breast cancer tissue array, with
metastasis tissue, including pathology grade, TNM and clinical stage, 80
cases/80 cores
|
|
138
|
BR8018
|
8
|
10
|
80
|
80
|
Breast
|
Breast invasive ductal carcinoma tissue array, including
pathology grade, TNM and clinical stage, 80 cases/80 cores, replacing BR808,
BC08014
|
|
139
|
BR802b
|
8
|
10
|
47
|
80
|
Breast
|
Breast invasive ductal carcinoma with matched or unmatched
adjacent normal breast tissue array, including pathology grade, TNM and
clinical stage, 47 cases/80 cores, replacing BR802
|
|
140
|
BR901
|
9
|
10
|
45
|
90
|
Breast
|
Breast cancer tissue array (pathology grade:1,2,3), including
pathology grade, TNM and clinical stage, 45 cases/90 cores
|
|
141
|
BR965
|
8
|
12
|
48
|
96
|
Breast
|
Breast cancer tissue array, including pathology grade, TNM and
clinical stage, 48 cases/96 cores, replacing BRC962
|
|
142
|
BRC051
|
1
|
5
|
5
|
5
|
Breast
|
Breast cancer tissue array with normal breast tissue, including
pathology grade, TNM, clinical stage, 5 cases/5 cores
|
|
143
|
BRE1121
|
10
|
12
|
112
|
112
|
Breast
|
Triple negative breast cancer with normal tissue array,
including pathology grade, TNM, clinical stage, 112 cases/112 cores
|
|
144
|
BRE1201
|
10
|
12
|
120
|
120
|
Breast
|
Breast cancer tissue array (most of triple negative), including
pathology grade, TNM, clinical stage, 120 cases/120 cores
|
|
145
|
BRE501
|
6
|
9
|
50
|
50
|
Breast
|
Breast cancer with breast tissue array (2012 WHO
classification), including pathology grade, TNM and clinical stage (AJCC 7th
edition), 50 cases/50 cores
|
|
146
|
BRE502
|
6
|
9
|
31
|
50
|
Breast
|
Breast cancer with breast tissue array, including pathology
grade, TNM and clinical stage, 31 cases/50 cores
|
|
147
|
BRN04
|
1
|
4
|
4
|
4
|
Breast
|
Breast tissue array, 4 cases/4 cores
|
|
148
|
FBR087d
|
3
|
8
|
6
|
24
|
Breast
|
Breast cancer with breast tissue array, including pathology
grade, TNM and clinical stage, 6 cases/24 cores, replacing T087c
|
|
149
|
FBR-245b
|
4
|
6
|
12
|
24
|
Breast
|
Breast cancer with adjacent normal tissue array (2012 WHO
classification), including pathology grade, TNM and clinical stage (AJCC 7th
edition), 12 cases/24 cores, replacing BR245a
|
|
150
|
FMG010
|
3
|
4
|
10
|
10
|
Breast
|
Breast invasive carcinoma of no special type tissue array,
including pathology grade, TNM, clinical stage, 10 cases/10 cores
|
|
151
|
FMG08013e
|
8
|
9
|
72
|
72
|
Breast
|
Breast cancer with adjacent normal breast tissue array,
including pathology grade, TNM and clinical stage, 72 cases/72 cores,
replacing BC08013d
|
|
152
|
FMG08013f
|
8
|
9
|
72
|
72
|
Breast
|
Breast cancer with adjacent normal breast tissue array,
including pathology grade, TNM and clinical stage, 72 cases/72 cores,
replacing FMG08013e
|
|
153
|
FMG082a
|
2
|
4
|
4
|
8
|
Breast
|
Breast cancer tissue array, including pathology grade, TNM and
clinical stage, 4 cases/8 cores, replacing BR082
|
|
154
|
FMG1001
|
10
|
10
|
96
|
100
|
Breast
|
Breast cancer and breast tissue array, with metastatic
carcinoma, including pathology grade, TNM and clinical stage, 96 cases/100
cores
|
|
155
|
FMG1003b
|
10
|
11
|
47
|
101
|
Breast
|
Multiple types breast cancer tissue array, including pathology
grade, TNM and clinical stage, 47 cases/101 cores, replacing BR1003a
|
|
156
|
FMG1009
|
10
|
10
|
50
|
100
|
Breast
|
Breast cancer tissue array with normal tissue, including
pathology grade, TNM and clinical stage, 50 cases/100 cores
|
|
157
|
FMG1021
|
8
|
13
|
102
|
102
|
Breast
|
Multiple types breast cancer tissue array with adjacent normal
tissue, including pathology grade, TNM and clinical stage, 102 cases/102
cores
|
|
158
|
FMG1141
|
11
|
11
|
114
|
114
|
Breast
|
Breast cancer tissue array, including pathology grade, TNM and
clinical stage, 114 cases/114 cores
|
|
159
|
FMG1503
|
10
|
15
|
75
|
150
|
Breast
|
Breast cancer tissue array, including pathology grade, TNM and
clinical stage, 75 cases/150 cores
|
|
160
|
FMG1504
|
10
|
15
|
75
|
150
|
Breast
|
Breast cancer tissue array with adjacent normal breast tissue,
including pathology grade, TNM and clinical stage, 75 cases/150 cores
|
|
161
|
FMG1505c
|
10
|
15
|
75
|
150
|
Breast
|
Breast cancer tissue array, including pathology grade, TNM and
clinical stage, 75 cases/150 cores, replacing BR1505b
|
|
162
|
FMG2088
|
13
|
16
|
104
|
208
|
Breast
|
Breast cancer tissue array, including pathology grade, TNM and
clinical stage, 104 cases/208 cores
|
|
163
|
FMG2089
|
13
|
16
|
104
|
208
|
Breast
|
Breast cancer tissue array, including pathology grade, TNM,
clinical stage, 104 cases/208 cores
|
|
164
|
FMG246
|
4
|
6
|
12
|
24
|
Breast
|
Breast carcinoma tissue array, including pathology grade, TNM
and clinical stage, 12 cases/24 cores, replacing BR245
|
|
165
|
FMG247
|
3
|
8
|
6
|
24
|
Breast
|
Breast cancer tissue array with adjacent normal tissue,
including pathology grade, TNM and clinical stage, 6 cases/24 cores
|
|
166
|
FMG251a
|
3
|
8
|
6
|
24
|
Breast
|
Breast cancer tissue array with matched adjacent normal breast
tissue, including pathology grade, TNM and clinical stage, 6 cases/24 cores,
replacing BR251
|
|
167
|
FMG251c
|
3
|
8
|
6
|
24
|
Breast
|
Breast cancer with matched breast tissue array, including
pathology grade, TNM and clinical stage, 6 cases/24 cores, replacing BR251b
|
|
168
|
FMG252
|
4
|
6
|
12
|
24
|
Breast
|
Breast cancer with matched breast tissue array, including
pathology grade, TNM and clinical stage, 12 cases/24 cores
|
|
169
|
FMG351
|
5
|
7
|
35
|
35
|
Breast
|
Low differentiated breast cancer tissue array, including pathology
grade, TNM and clinical stage, 35 cases/35 cores
|
|
170
|
FMG483b
|
6
|
8
|
48
|
48
|
Breast
|
Breast cancer tissue array with normal tissue, including
pathology grade, TNM and clinical stage, 48 cases/48 cores, replacing BR483
|
|
171
|
FMG483c
|
6
|
8
|
48
|
48
|
Breast
|
Breast cancer tissue array with normal tissue, including
pathology grade, TNM and clinical stage, 48 cases/48 cores, replacing BR483b
|
|
172
|
FMG484
|
6
|
8
|
48
|
48
|
Breast
|
Breast cancer tissue array, including TNM, clinical stage and
pathology grade, 48 cases/48 cores
|
|
173
|
FMG501
|
5
|
10
|
50
|
50
|
Breast
|
Breast cancer tissue array, including pathology grade, TNM and
clinical stage, 50 cases/ 50 cores
|
|
174
|
FMG631
|
7
|
9
|
45
|
63
|
Breast
|
Breast cancer tissue array, with adjacent normal tissue and
cancer adjacent breast tissue, including pathology grade, TNM and clinical
stage, 45 cases/63 cores
|
|
175
|
FMG721
|
8
|
9
|
72
|
72
|
Breast
|
Breast cancer tissue array, including pathology grade, TNM and
clinical stage, 72 cases/72 cores
|
|
176
|
FMG802c
|
8
|
10
|
54
|
80
|
Breast
|
Breast cancer with matched or unmatched breast tissue array,
including pathology grade, TNM and clinical stage, 54 cases/80 cores,
replacing BR802b
|
|
177
|
FMG803b
|
8
|
10
|
80
|
80
|
Breast
|
Breast cancer tissue array, including pathology grade, TNM and
clinical stage, 80 cases/80 cores, replacing BR803a
|
|
178
|
FMG805
|
8
|
10
|
80
|
80
|
Breast
|
Breast cancer tissue array, including TNM and clinical stage, 80
cases/80 cores
|
|
179
|
FMG807
|
8
|
10
|
80
|
80
|
Breast
|
Breast cancer tissue array, including TNM and clinical stage, 80
cases/80 cores
|
|
180
|
FMG809
|
8
|
10
|
80
|
80
|
Breast
|
Breast cancer tissue array with normal tissue, including
pathology grade, TNM and clinical stage, 80 cases/80 cores
|
|
181
|
HER2c
|
3
|
4
|
10
|
10
|
Breast
|
Her-2 IHC Bio-marker control TMA, with breast invasive carcinoma
of no special type, including pathology grade, TNM, clinical stage and, 10
cases/10 cores, replacing Her2b
|
|
182
|
PM2b-ER
|
3
|
4
|
10
|
10
|
Breast
|
Breast invasive carcinoma tissue array, including pathology
grade, TNM and clinical stage, 10 cases/ 10 cores
|
|
183
|
S-FMG133M
|
10
|
14
|
62
|
133
|
Breast
|
Triple negative breast tissue array with survival data,
including prognosis, pathology grade, TNM and clinical stage , 62 cases/133
cores
|
|
184
|
S-FMG140M
|
12
|
12
|
70
|
140
|
Breast
|
Breast carcinoma (Her2 3+) tissue array with survival data,
including prognosis, pathology grade, TNM and clinical stage, 70 cases/140
cores.
|
|
185
|
S-FMG142M
|
11
|
14
|
71
|
142
|
Breast
|
Breast carcinoma (HR) tissue array with survival data, including
prognosis, pathology grade, TNM and clinical stage, 71 cases/142 cores.
|
|
186
|
T088e
|
3
|
8
|
6
|
24
|
Breast
|
Breast cancer with breast tissue array, including pathology
grade, TNM and clinical stage, 6 cases/24 cores, replacing T088d
|
|
187
|
T089b
|
4
|
6
|
6
|
24
|
Breast
|
Breast cancer tissue array, including pathology grade, TNM and
clinical stage, 6 cases/24 cores, replacing T089a
|
|
188
|
FDU631
|
7
|
9
|
63
|
63
|
Cervix
|
Cervix cancer tissue array with adjacent normal and cancer
adjacent tissue, including pathology grade, TNM and clinical stage, 63
cases/63 cores
|
|
189
|
BIC05011
|
6
|
8
|
24
|
48
|
Colon
|
Colon intraepithelial neoplasia tissue array, 24 cases/48 cores
|
|
190
|
CO1006
|
10
|
10
|
50
|
100
|
Colon
|
Colon carcinoma tissue array, including pathology grade, TNM and
clinical stage, 50cases/100 cores
|
|
191
|
CO1021b
|
8
|
13
|
102
|
102
|
Colon
|
Colon cancer with colon tissue array, including pathology grade,
TNM and clinical stage, 102 cases/102 cores replacing CO1021a
|
|
192
|
CO1801b
|
10
|
18
|
90
|
180
|
Colon
|
Colon cancer with matched colon tissue array(2010 WHO
classification), including pathology grade, TNM and clinical stage (AJCC 7th
edition), 90 cases/180 cores, replacing CO1801a
|
|
193
|
CO2001b
|
13
|
16
|
200
|
200
|
Colon
|
Colon cancer with adjacent normal colon tissue array, including
pathology grade, TNM and clinical stage, 200 cases/ 200 cores, replacing
CO2001a
|
|
194
|
CO20811
|
13
|
16
|
208
|
208
|
Colon
|
Colon tumor survey tissue array (1 of 4), including pathology
grade, TNM and clinical stage, 208 cases/208 cores
|
|
195
|
CO20813
|
13
|
16
|
208
|
208
|
Colon
|
Colon tumor survey tissue array (3 of 4), including pathology
grade, TNM and clinical stage, 208 cases/208 cores
|
|
196
|
CO20814
|
13
|
16
|
208
|
208
|
Colon
|
Colon tumor survey tissue array (4 of 4), including pathology
grade, TNM and clinical stage, 208 cases/208 cores
|
|
197
|
CO2081a
|
13
|
16
|
104
|
208
|
Colon
|
Colon disease spectrum tissue array with normal tissue,
including pathology grade, TNM and clinical stage, 104 cases/208 cores,
replacing CO2081
|
|
198
|
CO2085b
|
13
|
16
|
208
|
208
|
Colon
|
High-density (208 cores), multiple types colon cancer tissue
array with normal colon tissue (from autopsy and adjacent normal tissue),
including pathology grade, TNM and clinical stage, 208 cases/208 cores,
replacing CO2085a
|
|
199
|
CO2161a
|
12
|
18
|
216
|
216
|
Colon
|
Colon cancer and colon tissue array, including pathology grade,
TNM and clinical stage, 216 cases/216 cores, replacing CO2161
|
|
200
|
CO483a
|
6
|
8
|
48
|
48
|
Colon
|
Colon cancer tissue array with normal tissue, including
pathology grade, TNM and clinical stage, 48 cases/48 cores, replacing CO483
|
|
201
|
CO486b
|
6
|
16
|
48
|
96
|
Colon
|
Colon cancer tissue array, including pathology grade, TNM and
clinical stage, 2 serial sections, 48 cases/96 cores, replacing CO486a
|
|
202
|
CO489d
|
6
|
8
|
24
|
48
|
Colon
|
Colon adenocarcinoma stage III tissue array, including pathology
grade, ,TNM and clinical stage, non-overlapping with other CO489, 24 cases/48
cores
|
|
203
|
CO489e
|
6
|
8
|
24
|
48
|
Colon
|
Colon adenocarcinoma stage III tissue array, including pathology
grade, TNM and clinical stage, non-overlapping with other CO489, 24 cases/ 48
cores
|
|
204
|
CO489f
|
6
|
8
|
24
|
48
|
Colon
|
Colon adenocarcinoma stage III tissue array, including pathology
grade, TNM and clinical stage, non-overlapping with other CO489, 24 cases/ 48
cores
|
|
205
|
CO489i
|
6
|
8
|
24
|
48
|
Colon
|
Colon adenocarcinoma stage III tissue array, including pathology
grade, TNM and clinical stage, non-overlapping with other CO489, 24 cases/48
cores
|
|
206
|
CO489j
|
6
|
8
|
24
|
48
|
Colon
|
Colon adenocarcinoma stage III tissue array, including pathology
grade, TNM and clinical stage, non-overlapping with other CO489, 24 cases/ 48
cores
|
|
207
|
CO489k
|
6
|
8
|
24
|
48
|
Colon
|
Colon adenocarcinoma stage III tissue array, including pathology
grade, TNM and clinical stage, non-overlapping with other CO489, 24 cases/ 48
cores
|
|
208
|
CO489n
|
6
|
8
|
24
|
48
|
Colon
|
Colon adenocarcinoma stage II tissue array, including pathology
grade, TNM and clinical stage, non-overlapping with other CO489, 24 cases/48
cores
|
|
209
|
CO489p
|
6
|
8
|
24
|
48
|
Colon
|
Colon adenocarcinoma stage II tissue array, including pathology
grade, TNM and clinical stage, non-overlapping with other CO489, 24 cases/48
cores
|
|
210
|
CO489q
|
6
|
8
|
24
|
48
|
Colon
|
Colon adenocarcinoma stage II tissue array, including pathology
grade, TNM and clinical stage, non-overlapping with other CO489, 24 cases/48
cores
|
|
211
|
CO489t
|
6
|
8
|
24
|
48
|
Colon
|
Colon adenocarcinoma stage II tissue array, including pathology
grade, TNM and clinical stage, non-overlapping with other CO489, 24 cases/48
cores
|
|
212
|
CO489u
|
6
|
8
|
24
|
48
|
Colon
|
Colon adenocarcinoma stage II tissue array, including pathology
grade, TNM and clinical stage, non-overlapping with other CO489, 24 cases/ 48
cores
|
|
213
|
CO602
|
6
|
10
|
30
|
60
|
Colon
|
Colon cancer with matched cancer adjacent colon tissue,
including pathology grade, TNM and clinical stage, 30 cases/60 cores
|
|
214
|
CO702c
|
7
|
10
|
69
|
69
|
Colon
|
Colon cancer and colon tissue array, with metastasis carcinoma,
including pathology grade, TNM and clinical stage, 69 cases/69 cores, replacing
CO702b
|
|
215
|
CO726
|
8
|
9
|
24
|
72
|
Colon
|
Metastatic carcinoma from colon tissue array, including
pathology grade, 24 cases/72 cores, replacing BC050112
|
|
216
|
CO802e
|
8
|
10
|
80
|
80
|
Colon
|
Colon cancer with adjacent normal colon tissue array, including pathology
grade, TNM and clinical stage, 80 cases/80 cores, replacing CO802d
|
|
217
|
CO803a
|
8
|
10
|
40
|
80
|
Colon
|
Colon cancer tissue array with matched cancer adjacent colon
tissue, including pathology grade, TNM and clinical stage, 40 cases/80 cores,
replacing CO803
|
|
218
|
CO804a
|
8
|
10
|
80
|
80
|
Colon
|
Colon cancer tissue array, including pathology grade, TNM and
clinical stage, 80 cases/80 cores, replacing CO804
|
|
219
|
CO809a
|
8
|
10
|
77
|
80
|
Colon
|
Colon disease tissue array , including pathology grade, TNM and
clinical stage, 80 cases/80 cores, replacing CO809
|
|
220
|
CO953
|
8
|
12
|
39
|
95
|
Colon
|
Colon cancer tissue array with matched normal adjacent and
matched or unmatched metastatic carcinoma tissue, including pathology grade,
TNM, clinical stage and survival data, 39 cases/95 cores, replacing CO952a
|
|
221
|
COL501
|
6
|
9
|
50
|
50
|
Colon
|
Colon adenocarcinoma with colon tissue array (2010 WHO
classification), including pathology grade, TNM and clinical stage (AJCC 7th
edition), 50 cases/50 cores
|
|
222
|
COL502
|
6
|
9
|
25
|
50
|
Colon
|
Colon adenocarcinoma with matched colon tissue array (2010 WHO
classification), including pathology grade, TNM and clinical stage (AJCC 7th
edition), 25 cases/50 cores
|
|
223
|
DCO053d
|
3
|
8
|
6
|
24
|
Colon
|
Colon cancer tissue array with normal tissue, including
pathology grade, TNM and clinical stage, 6 cases/24 cores, replacing T053c
|
|
224
|
DCO054d
|
3
|
8
|
12
|
24
|
Colon
|
Colon cancer tissue array with normal colon tissue, including
pathology grade, TNM and clinical stage, 12 cases/24 cores, replacing T054c
|
|
225
|
DCO054e
|
3
|
8
|
13
|
24
|
Colon
|
Colon cancer tissue array with normal colon tissue, including
pathology grade, TNM and clinical stage, 12 cases/ 24 cores, replacing T054d
|
|
226
|
DCO-055b
|
4
|
6
|
6
|
24
|
Colon
|
Colon cancer tissue array (4x(2x3) array), including pathology
grade, TNM and clinical stage, 6 cases/24 cores, replacing T055a
|
|
227
|
DCO1002c
|
10
|
10
|
64
|
100
|
Colon
|
Colorectal carcinoma and matched colon tissue array (2010 WHO
classification), with lymph node metastasis carcinoma, including pathology
grade, TNM and clinical stage (AJCC 7th edition), 64 cases/100 cores,
replacing CO1002b
|
|
228
|
DCO1003
|
10
|
10
|
100
|
100
|
Colon
|
Colon cancer with metastatic carcinoma tissue array, including
pathology grade, 100 cases/100 cores
|
|
229
|
DCO1005
|
10
|
10
|
100
|
100
|
Colon
|
Colon cancer and adenoma tissue array with normal tissue,
including pathology grade, TNM and clinical stage, 100 cases/100 cores
|
|
230
|
DCO-1021b
|
8
|
13
|
102
|
102
|
Colon
|
Colon cancer with colon tissue array, including pathology grade,
TNM and clinical stage, 102 cases/102 cores, replacing CO1021a
|
|
231
|
DCO1301
|
10
|
13
|
100
|
130
|
Colon
|
Colon adenocarcinoma tissue array with colon inflammation and
colon tissue, including pathology grade, TNM and clinical stage, 100
cases/130 cores
|
|
232
|
DCO1501a
|
10
|
15
|
75
|
150
|
Colon
|
Colon adenocarcinoma tissue array, including pathology grade,
TNM and clinical stage, 75 cases/150 cores
|
|
233
|
DCO1601
|
10
|
16
|
80
|
160
|
Colon
|
Colon cancer tissue array with matched adjacent normal or cancer
adjacent tissue, including pathology grade, TNM and clinical stage, 80
cases/160 cores
|
|
234
|
DCO-1801b
|
10
|
18
|
90
|
180
|
Colon
|
Colon cancer with matched colon tissue array (2010 WHO
classification), including pathology grade, TNM and clinical stage (AJCC 7th
edition), 90 cases/180 cores, replacing CO1801a
|
|
235
|
DCO20810
|
13
|
16
|
104
|
208
|
Colon
|
Colon tumor survey tissue array (5 of 5), including pathology
grade, TNM and clinical stage, 104 cases/208 cores
|
|
236
|
DCO20812
|
13
|
16
|
104
|
208
|
Colon
|
Colon cancer survey tissue array (2 of 4), including pathology
grade, TNM and clinical stage, 208 cases/208 cores, replacing CO20812
|
|
237
|
DCO2087
|
13
|
16
|
104
|
208
|
Colon
|
Colon tumor survey tissue array (2 of 5), including pathology
grade, TNM and clinical stage, 104 cases/208 cores
|
|
238
|
DCO241
|
4
|
6
|
6
|
24
|
Colon
|
Colon tissue and polyp tissue array, 6 cases/24 cores
|
|
239
|
DCO241b
|
3
|
8
|
6
|
24
|
Colon
|
Colon cancer tissue array with adjacent normal colon tissue,
including pathology grade, TNM and clinical stage, 6 cases/24 cores,
replacing CO241a
|
|
240
|
DCO243
|
4
|
6
|
9
|
24
|
Colon
|
Colon cancer tissue array with matched adjacent normal tissue,
including pathology grade, TNM and clinical stage, 9 cases/24 cores
|
|
241
|
DCO2601
|
13
|
20
|
65
|
260
|
Colon
|
Colon cancer tissue array with matched cancer adjacent colon
tissue, including pathology grade, TNM, clinical stage, 65 cases/260 cores
|
|
242
|
DCO321
|
4
|
8
|
16
|
32
|
Colon
|
Colon cancer (grade II) with matched adjacent normal colon
tissue, including pathology grade, TNM and clinical stage, 16 cases/32 cores
|
|
243
|
DCO351
|
5
|
7
|
35
|
35
|
Colon
|
Colon adenocarcinoma (grade I) tissue array, including pathology
grade, TNM and clinical stage, 35 cases/35 cores
|
|
244
|
DCO352
|
5
|
7
|
35
|
35
|
Colon
|
Colon adenocarcinoma tissue array, including pathology grade,
TNM and clinical stage, 35 cases/35 cores
|
|
245
|
DCO353
|
5
|
7
|
35
|
35
|
Colon
|
Colon adenocarcinoma (grade III) tissue array, including
pathology grade, TNM and clinical stage, 35 cases/35 cores, replacing CO353
|
|
246
|
DCO482a
|
6
|
8
|
24
|
48
|
Colon
|
Colon cancer with normal tissue array, including pathology
grade, TNM and clinical stage, 24 cases/48 cores
|
|
247
|
DCO484a
|
6
|
8
|
48
|
48
|
Colon
|
Colon cancer tissue array with adjacent normal tissues,
including pathology grade, TNM and clinical stage, 48 cases/48 cores,
replacing CO484
|
|
248
|
DCO488
|
6
|
8
|
16
|
48
|
Colon
|
Colon adenocarcinoma array with matched cancer adjacent colon
tissue, including pathology grade, TNM and clinical stage, 16 cases/48 cores
|
|
249
|
DCO489b
|
6
|
8
|
24
|
48
|
Colon
|
Colon adenocarcinoma stage III and stage IV tissue array,
including pathology grade, TNM and clinical stage, non-overlapping with other
CO489, 24 cases/48 cores
|
|
250
|
DCO489c
|
6
|
8
|
24
|
48
|
Colon
|
Colon adenocarcinoma stage III tissue array, including pathology
grade, TNM and clinical stage, non-overlapping with other CO489, 24 cases/48
cores
|
|
251
|
DCO489g
|
6
|
8
|
24
|
48
|
Colon
|
Colon adenocarcinoma stage III tissue array, including pathology
grade, TNM and clinical stage, non-overlapping with other CO489, 24 cases/48
cores
|
|
252
|
DCO489h
|
6
|
8
|
24
|
48
|
Colon
|
Colon adenocarcinoma stage III tissue array, including pathology
grade, TNM and clinical stage, non-overlapping with other CO489, 24 cases/48
cores
|
|
253
|
DCO489l
|
6
|
8
|
24
|
48
|
Colon
|
Colon adenocarcinoma stage III tissue array, including pathology
grade, TNM and clinical stage, non-overlapping with other CO489, 24 cases/48
cores
|
|
254
|
DCO489m
|
6
|
8
|
24
|
48
|
Colon
|
Colon adenocarcinoma stage II tissue array, including pathology
grade, TNM and clinical stage, non-overlapping with other CO489, 24 cases/48
cores
|
|
255
|
DCO489r
|
6
|
8
|
24
|
48
|
Colon
|
Colon adenocarcinoma stage II tissue array, including pathology
grade, TNM and clinical stage, non-overlapping with other CO489, 24 cases/48
cores
|
|
256
|
DCO489s
|
6
|
8
|
24
|
48
|
Colon
|
Colon adenocarcinoma stage II tissue array, including pathology
grade, TNM and clinical stage, non-overlapping with other CO489, 24 cases/48
cores
|
|
257
|
DCO601
|
6
|
10
|
30
|
60
|
Colon
|
Colon cancer (stage I) with matched cancer adjacent colon
tissue, including pathology grade, TNM and clinical stage, 30 cases/60 cores
|
|
258
|
DCO-701a
|
7
|
10
|
70
|
70
|
Colon
|
Colon cancer with colon tissue array (2010 WHO classification),
including pathology grade, TNM and clinical stage (AJCC 7th edition), 70
cases/70 cores, replacing CO701
|
|
259
|
DCO-702c
|
7
|
10
|
69
|
69
|
Colon
|
Colon cancer tissue array with metastatic cancer and normal
tissue (2010 WHO classification), including pathology grade, TNM and clinical
stage (AJCC 7th edition), 69 cases/69 cores, replacing CO702b
|
|
260
|
DCO703
|
7
|
10
|
35
|
70
|
Colon
|
Colon cancer tissue array with matched adjacent normal colon
tissue, including pathology grade, TNM and clinical stage, 35 cases/70 cores
|
|
261
|
DCO721
|
8
|
9
|
24
|
72
|
Colon
|
Colon normal tissue array, including pathology grade, TNM and
clinical stage, 24 cases/72 cores, replacing BN05011
|
|
262
|
DCO722a
|
8
|
9
|
24
|
72
|
Colon
|
Colon carcinoma, cancer adjacent and adjacent normal tissue
array, including pathology grade, TNM and clinical stage, 24 cases/72 cores
|
|
263
|
DCO723
|
8
|
9
|
24
|
72
|
Colon
|
Colon well-differentiated adenocarcinoma tissue array with
adjacent normal tissue, including pathology grade, TNM and clinical stage, 24
cases/72 cores, replacing BS05021
|
|
264
|
DCO724
|
8
|
9
|
24
|
72
|
Colon
|
Colon moderately differentiated adenocarcinoma tissue array with
adjacent normal tissue, including pathology grade, TNM and clinical stage, 24
cases/72 cores, replacing BS05031
|
|
265
|
DCO8010
|
8
|
10
|
80
|
80
|
Colon
|
Mid-advanced stage colon cancer tissue array, including
pathology grade, TNM and clinical stage, 80 cases/80 cores
|
|
266
|
DCO802c
|
8
|
10
|
80
|
80
|
Colon
|
Colon cancer tissue array with adjacent normal colon tissue,
including pathology grade, TNM and clinical stage, 80 cases/80 cores,
replacing CO802b
|
|
267
|
DCO803b
|
8
|
10
|
40
|
80
|
Colon
|
Colon cancer tissue array with matched cancer adjacent colon
tissue, including pathology grade, TNM and clinical stage, 40 cases/80 cores
|
|
268
|
DCO901
|
9
|
10
|
50
|
90
|
Colon
|
Colon cancer tissue array with adjacent normal colon tissue,
including pathology grade, TNM and clinical stage, 50 cases/90 cores
|
|
269
|
DCO963
|
8
|
12
|
48
|
96
|
Colon
|
Colon adenocarcinoma (grade II) tissue array, including
pathology grade, TNM and clinical stage, 48 cases/96 cores
|
|
270
|
DCOL721
|
8
|
9
|
72
|
72
|
Colon
|
Colon cancer tissue array, including pathology grade, TNM and
clinical stage, 72 cases/72 cores
|
|
271
|
DCR1201
|
10
|
12
|
60
|
120
|
Colon
|
Colorectal cancer tissue array with matched adjacent normal or
cancer adjacent tissue, including pathology grade, TNM and clinical stage, 60
cases/120 cores
|
|
272
|
S-CRAC1601C
|
8
|
10
|
80
|
80
|
Colon
|
Colon cancer tissue microarray chip with survival data, 80
cases/80 cores.
|
|
273
|
S-CRAC3204M
|
10
|
16
|
80
|
160
|
Colon
|
Colon cancer tissue/matched normal tissue array with survival
data, including survival status, pathology grade, TNM and clinical stage, 80
cases/160 cores
|
|
274
|
T056a
|
4
|
6
|
12
|
24
|
Colon
|
Colon cancer with colon tissue array, including pathology grade,
TNM and clinical stage, 6 cases/24 cores, replacing T056
|
|
275
|
EMT241
|
3
|
8
|
6
|
24
|
Embryonic Tumors
|
Embryonal tumor test tissue array, with normal tissue, including
pathology grade, TNM and clinical stage, 6 cases/24 cores, replacing T001
|
|
276
|
FUR1001
|
10
|
10
|
25
|
100
|
Endometrium
|
Endometrial cancer tissue array for antibody screening,
including pathology grade, TNM and clinical stage, 25 cases/100 cores
|
|
277
|
FUR1021
|
8
|
13
|
102
|
102
|
Endometrium
|
Endometrial cancer tissue array, including pathology grade, TNM
and clinical stage, 102 cases/102 cores
|
|
278
|
FUR1021b
|
8
|
13
|
102
|
102
|
Endometrium
|
Endometrium cancer with endometrium tissue array, including
pathology grade, TNM and clinical stage, 102 cases/102 cores, replacing
EM1021a
|
|
279
|
FUR1501
|
10
|
15
|
75
|
150
|
Endometrium
|
Uterus cancer tissue array, including pathology grade, TNM and
clinical stage, 75 cases/150 cores
|
|
280
|
FUR1502
|
10
|
15
|
75
|
150
|
Endometrium
|
Endometrium cancer tissue array, including pathology grade, TNM
and clinical stage, 75 cases/150 cores
|
|
281
|
FUR240
|
4
|
6
|
24
|
24
|
Endometrium
|
Endometrium cancer, endometrium hyperplasia tissue array with
adjacent tissue as control, including pathology grade, TNM and clinical
stage, 24 cases/24 cores
|
|
282
|
FUR241
|
3
|
8
|
12
|
24
|
Endometrium
|
Endometrium cancer test tissue array with normal tissue,
including pathology grade, TNM and clinical stage, 12cases/24cores, replacing
T092
|
|
283
|
FUR242
|
4
|
6
|
6
|
24
|
Endometrium
|
Endometrium cancer test tissue array (4x (2x3)array), including
pathology grade, TNM and clinical stage, 6 cases/24 cores
|
|
284
|
FUR243b
|
4
|
6
|
12
|
24
|
Endometrium
|
Endometrium cancer tissue array with matched cancer adjacent
endometrium tissue, including pathology grade, TNM and clinical stage, 12
cases/24 cores, replacing UT243a
|
|
285
|
FUR244
|
4
|
6
|
12
|
24
|
Endometrium
|
Chorionic carcinoma with endometrium tissue array, including TNM
and clinical stage, 12 cases/24 cores
|
|
286
|
FUR244a
|
4
|
6
|
12
|
24
|
Endometrium
|
Chorionic carcinoma with endometrium tissue array, including TNM
and clinical stage, 12 cases/24 cores
|
|
287
|
FUR481
|
6
|
8
|
48
|
48
|
Endometrium
|
Endometrium cancer tissue array, including pathology grade, TNM
and clinical stage, 48 cases/48 cores
|
|
288
|
FUR501b
|
5
|
10
|
50
|
50
|
Endometrium
|
Endometrioid carcinoma tissue array with normal tissue,
including pathology grade, TNM and clinical stage, 50 cases/50 cores,
replacing UT501a
|
|
289
|
FUR631
|
7
|
9
|
63
|
63
|
Endometrium
|
Endometrioid cancer tissue array, including pathology grade, TNM
and clinical stage, 63 cases/63 cores
|
|
290
|
FUR721
|
8
|
9
|
24
|
72
|
Endometrium
|
Uterus cancer with normal tissue array, including pathology
grade, TNM and clinical stage, 24 cases/72 cores
|
|
291
|
FUR801b
|
8
|
10
|
80
|
80
|
Endometrium
|
Endometrial disease spectrum (endometrial cancer progression)
tissue array, including pathology grade, TNM and clinical stage, 80 cases/80
cores, replacing UT801a
|
|
292
|
FUR803
|
8
|
10
|
40
|
80
|
Endometrium
|
Uterus cancer with endometrium tissue array, including pathology
grade, TNM and clinical stage, 40 cases/80 cores
|
|
293
|
UT243
|
4
|
6
|
12
|
24
|
Endometrium
|
Endometrium cancer tissue array with matched adjacent
endometrium tissue, including TNM, clinical stage and pathology grade, 12
cases/24 cores
|
|
294
|
UTN801a
|
8
|
10
|
79
|
80
|
Endometrium
|
Endometrium tissue and endometrium cancer tissue array, including
pathology grade, TNM and clinical stage, 79 cases/80 cores, replacing UTN801
|
|
295
|
KIN601
|
6
|
10
|
60
|
60
|
Epiploon
|
Metastatic carcinoma of epiploon
|
|
296
|
BC001113a
|
7
|
8
|
50
|
50
|
Esophagus
|
Esophagus, cardia cancer tissue array with normal tissue,
including pathology grade, TNM and clinical stage, 50 cases/50 cores,
replacing BC001113
|
|
297
|
BC001113b
|
7
|
8
|
50
|
50
|
Esophagus
|
Esophagus, cardia cancer tissue array with cancer adjacent
tissue, including pathology grade, TNM and clinical stage, 50 cases/50 cores,
replacing BC001113a
|
|
298
|
BN02014
|
8
|
10
|
80
|
80
|
Esophagus
|
Esophagus tissue with esophagus cancer tissue array, including
pathology grade, TNM and clinical stage, 80 cases/80 cores
|
|
299
|
DES02012
|
8
|
9
|
72
|
72
|
Esophagus
|
Esophagus cancer with adjacent normal esophagus tissue array,
including pathology grade, TNM and clinical stage, 72 cases/72 cores
|
|
300
|
DES02012b
|
8
|
9
|
72
|
72
|
Esophagus
|
Esophagus cancer with adjacent normal esophagus tissue array,
including pathology grade, TNM and clinical stage, 72 cases/72 cores,
replacing BC02012a
|
|
301
|
DES1002
|
10
|
10
|
50
|
100
|
Esophagus
|
Esophagus cancer tissue array, including pathology grade, TNM
and clinical stage, 50 cases/100 cores
|
|
302
|
DES1021
|
8
|
13
|
102
|
102
|
Esophagus
|
Esophagus cancer tissue array, including pathology grade, TNM
and clinical stage, 102 cases/102 cores
|
|
303
|
DES1022
|
8
|
13
|
102
|
102
|
Esophagus
|
Different stages of esophagus cancer and esophagus tissue array,
including pathology grade, TNM and clinical stage, 102 cases/102 cores
|
|
304
|
DES1202
|
10
|
12
|
60
|
120
|
Esophagus
|
Esophagus squamous cell carcinoma tissue array with matched
adjacent normal or cancer adjacent esophagus tissue, including pathology
grade, TNM and clinical stage, 60 cases/120 cores
|
|
305
|
DES1501
|
10
|
15
|
75
|
150
|
Esophagus
|
Esophagus squamous cell carcinoma with esophagus tissue array,
including pathology grade, TNM and clinical stage, 75 cases/150 cores
|
|
306
|
DES1502
|
10
|
15
|
75
|
150
|
Esophagus
|
Esophagus cancer tissue array, including pathology grade, TNM
and clinical stage, 75 cases/150 cores
|
|
307
|
DES1503
|
10
|
15
|
50
|
150
|
Esophagus
|
Esophagus cancer tissue array with matched cancer adjacent
tissue, including pathology grade, TNM and clinical stage, 50 cases/150 cores
|
|
308
|
DES1504
|
10
|
15
|
50
|
150
|
Esophagus
|
Esophagus cancer tissue array with matched cancer adjacent
tissue, including pathology grade, TNM and clinical stage, 50 cases/150 cores
|
|
309
|
DES1505
|
10
|
15
|
50
|
150
|
Esophagus
|
Esophagus squamous cell carcinoma with matched cancer adjacent
tissue and esophagus lymph node tissue array, including pathology grade, TNM
and clinical stage, 50 cases/150 cores
|
|
310
|
DES1921
|
12
|
16
|
96
|
192
|
Esophagus
|
Middle-advanced stage esophagus cancer tissue array, including
pathology grade, TNM and clinical stage, 96 cases/192 cores
|
|
311
|
DES1922
|
12
|
16
|
96
|
192
|
Esophagus
|
Esophagus squamous cell carcinoma with matched adjacent normal
esophagus tissue array, including pathology grade, TNM and clinical stage, 96
cases/192 cores
|
|
312
|
DES208
|
13
|
16
|
64
|
192
|
Esophagus
|
Esophagus cancer with esophagus tissue array, with metastatic
carcinoma, including pathology grade, TNM and clinical stage, 69 cases/208
cores
|
|
313
|
DES241
|
3
|
8
|
12
|
24
|
Esophagus
|
Esophagus cancer test tissue array with normal tissue, including
pathology grade, TNM and clinical stage, 12 cases/24 cores, replacing T022
|
|
314
|
DES242
|
3
|
8
|
12
|
24
|
Esophagus
|
Esophagus cancer array with normal tissue, including pathology
grade, TNM and clinical stage, 12 cases/ 24 cores, replacing T022a
|
|
315
|
DES243
|
3
|
8
|
12
|
24
|
Esophagus
|
Esophagus cancer array with normal tissue, including pathology
grade, TNM and clinical stage, 12 cases/24 cores, replacing T022b
|
|
316
|
DES244
|
4
|
6
|
12
|
24
|
Esophagus
|
Esophagus squamous cell carcinoma tissue array with matched
cancer adjacent tissue, including pathology grade, TNM and clinical stage, 12
cases/24 cores, replacing ESC241
|
|
317
|
DES245
|
4
|
6
|
6
|
24
|
Esophagus
|
Esophagus cancer test tissue array (4x (2x3)array), including
pathology grade, TNM and clinical stage, 6 cases/24 cores
|
|
318
|
DES352
|
5
|
7
|
35
|
35
|
Esophagus
|
Esophagus squamous cell carcinoma (grade II) tissue array,
including pathology grade, TNM and clinical stage, 35 cases/35 cores
|
|
319
|
DES353
|
5
|
7
|
35
|
35
|
Esophagus
|
Esophagus squamous cell carcinoma (grade III) tissue array,
including pathology grade, TNM and clinical stage, 35 cases/35 cores
|
|
320
|
DES483
|
6
|
8
|
16
|
48
|
Esophagus
|
Esophagus cancer with matched cancer adjacent tissue array,
including pathology grade, TNM and clinical stage, 16 cases/48 cores
|
|
321
|
DES484
|
6
|
8
|
24
|
48
|
Esophagus
|
Esophagus cancer tissue array, including pathology grade, TNM
and clinical stage, 24 cases/ 48 cores
|
|
322
|
DES502
|
5
|
10
|
50
|
50
|
Esophagus
|
Esophagus squamous cell carcinoma tissue array, including
pathology grade, TNM and clinical stage, 50 cases/50 cores
|
|
323
|
DES601
|
6
|
10
|
30
|
60
|
Esophagus
|
Esophagus squamous cell carcinoma tissue array with matched
cancer adjacent esophagus tissue, including pathology grade, TNM and clinical
stage, 30 cases/60 cores
|
|
324
|
DES701
|
7
|
10
|
35
|
70
|
Esophagus
|
Esophagus cancer tissue array with matched adjacent normal
esophagus tissue, including pathology grade, TNM and clinical stage, 35
cases/70 cores
|
|
325
|
DES702
|
7
|
10
|
35
|
70
|
Esophagus
|
Multiple esophagus cancer tissue array with matched cancer
adjacent normal tissue, including pathology grade, TNM and clinical stage, 35
cases/70 cores
|
|
326
|
DES721
|
8
|
9
|
72
|
72
|
Esophagus
|
Esophagus disease spectrum (esophageal cancer progression)
tissue array, including pathology grade, TNM and clinical stage, 72 cases/72
cores
|
|
327
|
DES722
|
8
|
9
|
24
|
72
|
Esophagus
|
Esophagus cancer with esophagus tissue array, including
pathology grade, TNM and clinical stage, 24 cases/72 cores
|
|
328
|
DES723
|
8
|
9
|
23
|
72
|
Esophagus
|
Esophagus cancer tissue array with adjacent normal tissue,
including pathology grade, TNM and clinical stage, 23 cases/ 72 cores
|
|
329
|
DES8011a
|
8
|
10
|
40
|
80
|
Esophagus
|
Esophagus cancer and normal tissue array, including pathology grade,
TNM and clinical stage, 40 cases/80 cores, replacing ES8011
|
|
330
|
DES8012
|
8
|
10
|
80
|
80
|
Esophagus
|
Middle-advanced stage esophagus cancer tissue array with
metastasis tissue, including pathology grade, TNM and clinical stage, 80
cases/80 cores
|
|
331
|
DES901
|
10
|
9
|
30
|
90
|
Esophagus
|
Esophagus cancer and esophagus tissue array, including pathology
grade, TNM and clinical stage, 30 cases/90 cores
|
|
332
|
DES902
|
10
|
9
|
45
|
90
|
Esophagus
|
Esophagus cancer with adjacent normal esophagus tissue array,
including pathology grade, TNM and clinical stage, 45 cases/90 cores
|
|
333
|
DES961
|
8
|
12
|
48
|
96
|
Esophagus
|
Esophagus squamous cell carcinoma tissue array with normal
tissue, including pathology grade, TNM and clinical stage, 48 cases/96 cores
|
|
334
|
DES962
|
8
|
12
|
48
|
96
|
Esophagus
|
Esophagus cancer tissue array, including pathology grade, TNM
and clinical stage, 48 cases/96 cores, replacing ESC962
|
|
335
|
DES966
|
12
|
8
|
48
|
96
|
Esophagus
|
Esophagus cancer tissue array, including pathology grade, TNM
and clinical stage, 48 cases/96 cores
|
|
336
|
DLV244
|
4
|
6
|
8
|
24
|
Esophagus
|
Liver cancer tissue array, including pathology grade, TNM and
clinical stage, 8 cases/24 cores
|
|
337
|
ES2001a
|
13
|
16
|
120
|
200
|
Esophagus
|
Esophagus squamous cell carcinoma with matched adjacent normal
esophagus tissue and metastatic carcinoma tissue array, including pathology
grade, TNM and clinical stage, 120 cases/200 cores, replacing ES2001
|
|
338
|
ES208b
|
12
|
16
|
64
|
192
|
Esophagus
|
Esophagus cancer and esophagus tissue array, with metastatic
carcinoma, including pathology grade, TNM and clinical stage, 64 cases/192
cores, replacing ES208a
|
|
339
|
ES351
|
5
|
7
|
35
|
35
|
Esophagus
|
Esophagus squamous cell carcinoma tissue array, including
pathology grade, TNM and clinical stage, 35 cases/35 cores
|
|
340
|
ES810a
|
8
|
10
|
40
|
80
|
Esophagus
|
Esophagus cancer with matched lymph node metastatic carcinoma
tissue array, including pathology grade, TNM and clinical stage, 40 cases/80
cores, replacing ES810
|
|
341
|
ESO501
|
6
|
9
|
50
|
50
|
Esophagus
|
Esophagus squamous cell carcinoma with esophagus tissue array
(2010 WHO classification), including pathology grade, TNM and clinical stage
(AJCC 7th edition), 50 cases/50 cores
|
|
342
|
ESO502
|
6
|
9
|
25
|
50
|
Esophagus
|
Esophagus cancer with matched esophagus tissue array (2010 WHO
classification), including pathology grade, TNM and clinical stage (small
cell carcinoma reference AJCC 8th edition), 25 cases/50 cores
|
|
343
|
T021b
|
3
|
8
|
6
|
24
|
Esophagus
|
Esophagus cancer tissue array with normal tissue, including
pathology grade, TNM and clinical stage, 6 cases/24 cores, replacing T021a
|
|
344
|
FUT241
|
3
|
8
|
6
|
24
|
Fallopian Tube
|
Uterine tube tumor with uterine tube tissue test array,
including pathology grade, TNM and clinical stage, 6 cases/24 cores
|
|
345
|
FET541
|
6
|
9
|
14
|
54
|
Fetus
|
Fetal multiple organ normal tissue array, 14 cases/54 cores
|
|
346
|
FET781
|
9
|
9
|
4
|
78
|
Fetus
|
Fetal multiple organ normal tissue array, 4 cases/78 cores
|
|
347
|
FET782
|
6
|
12
|
10
|
72
|
Fetus
|
Different gestational age of fetal multiple organ normal tissue
array, 10 cases/72 cores
|
|
348
|
PLA241
|
4
|
6
|
12
|
24
|
Fetus
|
Placenta tissue array, 12 cases/24 cores
|
|
349
|
HNN501
|
6
|
9
|
50
|
50
|
Head Neck
|
Head and neck squamous cell carcinoma and normal tissue array
(2017 WHO classification), including pathology grade, TNM and clinical stage
(AJCC 8th edition),50 cases/50 cores
|
|
350
|
HNN502
|
6
|
9
|
25
|
50
|
Head Neck
|
Head and neck tumor and matched normal tissue array (2017 WHO
classification), including pathology grade, TNM and clinical stage (AJCC 8th
edition), 25 cases/50 cores
|
|
351
|
XHN241
|
3
|
8
|
6
|
24
|
Head Neck
|
Head and neck cancer with matched adjacent normal tissue array, including
pathology grade, TNM and clinical stage, 6 cases/24 cores
|
|
352
|
XHN-242c
|
4
|
6
|
12
|
24
|
Head Neck
|
Head and neck cancer with normal tissue array, including
pathology grad, TNM and clinical stage, 12 cases/24 cores, replacing HN242b
|
|
353
|
XHN243
|
4
|
6
|
12
|
24
|
Head Neck
|
Head and neck cancer with normal tissue array, including
pathology grade, TNM and clinical stage, 12 cases/24 cores
|
|
354
|
XHN483
|
6
|
8
|
48
|
48
|
Head Neck
|
Head and neck cancer with normal tissue array, including
pathology grade, TNM and clinical stage, 48 cases/48 cores
|
|
355
|
XHN801
|
8
|
10
|
40
|
80
|
Head Neck
|
Head and neck squamous cell carcinoma tissue array, including
pathology grade, TNM and clinical stage, 40 cases/80 cores
|
|
356
|
XHN-802c
|
8
|
10
|
80
|
80
|
Head Neck
|
Multiple head and neck tumor with normal tissue array (2005 WHO
classification), including pathology grade, TNM and clinical stage (AJCC 8th
edition), 80 cases/80 cores, replacing HN802b
|
|
357
|
XHN803
|
8
|
10
|
80
|
80
|
Head Neck
|
Head and neck cancer tissue array with normal tissue, including
pathology grade, TNM and clinical stage, 80 cases/80 cores
|
|
358
|
XHN811
|
9
|
9
|
27
|
81
|
Head Neck
|
Head and neck tumor tissue array with normal tissue, including
pathology grade, TNM and clinical stage, 27 cases/81 cores
|
|
359
|
MHN241
|
4
|
6
|
6
|
24
|
Head Neck
|
Head and neck cancer tissue array, including pathology grade,
TNM and clinical stage, 6 cases/24 cores
|
|
360
|
BC30013a
|
6
|
6
|
18
|
36
|
Heart
|
Heart disease and heart tissue array, 18 cases/36 cores,
replacing BC30013
|
|
361
|
CHT241
|
3
|
8
|
6
|
24
|
Heart
|
Heart tumor and cardiac muscle tissue test array, including TNM
and pathology grade, 2 serial sections, 6 cases/24 cores
|
|
362
|
HEN241
|
4
|
6
|
24
|
24
|
Heart
|
Normal heart tissue array, 24 cases/24 cores
|
|
363
|
ISN241
|
4
|
6
|
24
|
24
|
Immune System
|
Normal immune system tissue array, 24 cases/ 24 cores
|
|
364
|
MC1081a
|
11
|
10
|
108
|
108
|
Immune System
|
Immune multiple organs tumor and normal tissue array, 108
cases/108 cores, replacing MC1081
|
|
365
|
DIN1021
|
9
|
12
|
34
|
102
|
Intestine
|
Small intestine carcinoma tissue array with matched small
intestine tissue, including pathology grade, TNM and clinical stage, 34
cases/102 cores
|
|
366
|
DIN1401
|
10
|
14
|
70
|
140
|
Intestine
|
Small intestine carcinoma tissue array with small intestine
tissue, including pathology grade, TNM and clinical stage, 70 cases/140 cores
|
|
367
|
DIN241
|
4
|
6
|
6
|
24
|
Intestine
|
Small intestine adenocarcinoma and adjacent normal tissue array,
including pathology grade, 6 cases/24 cores
|
|
368
|
DIN242
|
4
|
6
|
12
|
24
|
Intestine
|
Small intestine adenocarcinoma with small intestine tissue
array, including pathology grade, 12 cases/24 cores
|
|
369
|
DIN243
|
3
|
8
|
6
|
24
|
Intestine
|
Small intestine cancer with small intestine test array,
including pathology grade, TNM and clinical stage, 6 cases/24 cores
|
|
370
|
DIN805
|
8
|
10
|
80
|
80
|
Intestine
|
Small intestine disease spectrum tissue array, including
pathology grade, TNM and clinical stage, 80 cases/80 cores
|
|
371
|
DIN901
|
9
|
10
|
34
|
90
|
Intestine
|
Small intestine stromal tumor tissue array, 34 cases/90 cores
|
|
372
|
T421a
|
3
|
8
|
6
|
24
|
Intestine
|
Small intestine carcinoma test tissue array with normal small
intestine tissue, including pathology grade, TNM and clinical stage, 6
cases/24 cores, replacing T421
|
|
373
|
KD20810
|
13
|
16
|
208
|
208
|
Kidney
|
Kidney cancer survey tissue array (1 of 3), with normal tissue,
including pathology grade, TNM and clinical stage, 208 cases/208 cores
|
|
374
|
KD20811
|
13
|
16
|
208
|
208
|
Kidney
|
Kidney cancer survey tissue array (2 of 3), including pathology
grade, TNM and clinical stage, 208 cases/208 cores
|
|
375
|
KD20812
|
13
|
16
|
208
|
208
|
Kidney
|
Kidney cancer survey tissue array(3 of 3), including pathology
grade, TNM and clinical stage, 208 cases/208 cores
|
|
376
|
KD2082b
|
12
|
16
|
96
|
192
|
Kidney
|
Kidney cancer with kidney tissue array, including pathology
grade, TNM and clinical stage, 96 cases/192 cores, replacing KD2082a
|
|
377
|
KD601
|
6
|
10
|
30
|
60
|
Kidney
|
Kidney clear cell cancer tissue array with matched cancer
adjacent kidney tissue, including pathology grade, TNM and clinical stage,
pathology grade I-III, 30 cases/60 cores
|
|
378
|
KD602
|
6
|
10
|
30
|
60
|
Kidney
|
Kidney cancer tissue array with matched kidney tissue, including
ISUP grade, TNM, stage and survival data, 30 cases/60 cores
|
|
379
|
KD801b
|
8
|
10
|
40
|
80
|
Kidney
|
Kidney cancer with matched kidney tissue array, including
pathology grade, TNM and clinical stage, 40 cases/80 cores, replacing KD801a
|
|
380
|
KD991a
|
11
|
9
|
33
|
99
|
Kidney
|
Kidney cancer, cancer adjacent and adjacent normal kidney tissue
array, including pathology grade, TNM and clinical stage, 33 cases/99 cores,
replacing KD991
|
|
381
|
KID501
|
6
|
9
|
50
|
50
|
Kidney
|
Kidney clear cell carcinoma with kidney tissue array (2016 WHO classification),
including pathology grade, TNM and clinical stage (AJCC 7th edition), 50
cases/50 cores
|
|
382
|
KID502
|
6
|
9
|
25
|
50
|
Kidney
|
Multiple kidney cancer with matched kidney tissue array (2016
WHO classification), including pathology grade, TNM and clinical stage (AJCC
7th edition), 25 cases/50 cores
|
|
383
|
T071a
|
3
|
8
|
6
|
24
|
Kidney
|
Kidney cancer test tissue array with normal kidney tissues,
including pathology grade, TNM and clinical stage, 6 cases/24 cores,
replacing T071
|
|
384
|
UKD-461
|
6
|
8
|
23
|
46
|
Kidney
|
Multiple kidney cancer with matched kidney tissue array (2016
WHO classification), including pathology grade, TNM and clinical stage (AJCC
7th edition), 23 cases/46 cores
|
|
385
|
UKN1002
|
10
|
10
|
50
|
100
|
Kidney
|
Kidney cancer tissue array with adjacent normal tissue,
including pathology grade, TNM and clinical stage, 50 cases/100 cores
|
|
386
|
UKN1501
|
10
|
15
|
75
|
150
|
Kidney
|
Kidney cancer tissue array, including pathology grade, TNM and
clinical stage, 75 cases/150 cores
|
|
387
|
UKN1503
|
10
|
15
|
50
|
150
|
Kidney
|
Kidney cancer tissue array with matched kidney tissue, including
pathology grade, TNM and clinical stage, 50 cases/150 cores
|
|
388
|
UKN1504
|
10
|
15
|
50
|
150
|
Kidney
|
Kidney cancer tissue array with matched cancer adjacent tissue,
including pathology grade, TNM and clinical stage, 50 cases/150 cores
|
|
389
|
UKN1921
|
12
|
16
|
96
|
192
|
Kidney
|
Middle-advanced stage kidney cancer tissue array, including
pathology grade, TNM and clinical stage, 96 cases/192 cores
|
|
390
|
UKN2086
|
13
|
16
|
104
|
208
|
Kidney
|
Kidney tumor survey tissue array (2 of 5), including pathology
grade, TNM and clinical stage, 104 cases/208 cores
|
|
391
|
UKN2087
|
13
|
16
|
104
|
208
|
Kidney
|
Kidney cancer survey tissue array(3 of 5), including pathology
grade, TNM and clinical stage, 104 cases/208 cores
|
|
392
|
UKN2088
|
13
|
16
|
104
|
208
|
Kidney
|
Kidney cancer survey tissue array (4 of 5), including pathology
grade, TNM and clinical stage, 104 cases/208 cores
|
|
393
|
UKN241
|
3
|
8
|
12
|
24
|
Kidney
|
Kidney cancer test tissue array with normal tissue, including
pathology grade, TNM and clinical stage, 12 cases/24 cores, replacing T072
|
|
394
|
UKN242
|
4
|
6
|
6
|
24
|
Kidney
|
Kidney cancer test tissue array (4x (2x3)array), including
pathology grade, TNM and clinical stage, 6 cases/24 cores
|
|
395
|
UKN243
|
4
|
12
|
48
|
48
|
Kidney
|
Kidney cancer tissue array with normal tissue, including
pathology grade, TNM and clinical stage, 24 cases/48 cores
|
|
396
|
UKN244
|
4
|
6
|
24
|
24
|
Kidney
|
Normal kidney and cancer adjacent tissue array, 24 cases/ 24
cores
|
|
397
|
UKN246
|
4
|
6
|
24
|
24
|
Kidney
|
Transitional cell carcinoma of renal pelvis tissue array, including
pathology grade, TNM and clinical stage, 24 cases/24 cores
|
|
398
|
UKN247
|
4
|
6
|
12
|
24
|
Kidney
|
Kidney cancer tissue array with matched cancer adjacent tissue,
including pathology grade, TNM and clinical stage, 12 cases/24 cores
|
|
399
|
UKN2601
|
13
|
20
|
65
|
260
|
Kidney
|
Kidney cancer tissue array with matched cancer adjacent kidney
tissue, including pathology grade, TNM and clinical stage, 65 cases/260 cores
|
|
400
|
UKN2602
|
13
|
20
|
65
|
260
|
Kidney
|
Kidney cancer tissue array with matched cancer adjacent kidney
tissue, including pathology grade, TNM and clinical stage, 65 cases/260 cores
|
|
401
|
UKN321
|
4
|
8
|
16
|
32
|
Kidney
|
Kidney cancer tissue array with matched adjacent normal tissue,
including pathology grade, TNM and clinical stage, 16 cases/32 cores
|
|
402
|
UKN482
|
7
|
8
|
24
|
48
|
Kidney
|
Kidney cancer with normal tissue array, including pathology
grade, TNM and clinical stage, 24 cases/ 48 cores
|
|
403
|
UKN483
|
6
|
8
|
48
|
48
|
Kidney
|
Kidney cancer tissue array with adjacent normal tissue,
including pathology grade, TNM, clinical stage, 48 cases/48 cores
|
|
404
|
UKN484
|
6
|
8
|
48
|
48
|
Kidney
|
Kidney cancer tissue array, including pathology grade, TNM and
clinical stage, 48 cases/48 cores
|
|
405
|
UKN485
|
6
|
8
|
48
|
48
|
Kidney
|
Kidney cancer tissue array with normal tissue, including
pathology grade, TNM, clinical stage, 48 cases/48 cores
|
|
406
|
UKN487
|
6
|
8
|
24
|
48
|
Kidney
|
Pediatric nephroblastoma tissue array, 24 cases/48 cores
|
|
407
|
UKN601
|
6
|
10
|
30
|
60
|
Kidney
|
Kidney clear cell cancer tissue array with matched kidney
tissue, including pathology grade, TNM, 30 cases/60 cores
|
|
408
|
UKN602
|
6
|
10
|
30
|
60
|
Kidney
|
Different stage of kidney cancer tissue array with cancer
adjacent tissue, including pathology grade, TNM and clinical stage, 30
cases/60 cores
|
|
409
|
UKN641
|
8
|
8
|
64
|
64
|
Kidney
|
Kidney cancer tissue array, including pathology grade, TNM and
clinical stage, 64 cases/ 64 cores
|
|
410
|
UKN701
|
7
|
10
|
35
|
70
|
Kidney
|
Kidney cancer (grade I) tissue array with matched adjacent
normal kidney tissue, including pathology grade, TNM and clinical stage, 35
cases/70 cores
|
|
411
|
UKN702
|
7
|
10
|
35
|
70
|
Kidney
|
Kidney cancer tissue array with matched adjacent normal kidney
tissue, including pathology grade, TNM and clinical stage, 35 cases/70 cores
|
|
412
|
UKN804
|
8
|
10
|
80
|
80
|
Kidney
|
Multiple pathological types of kidney carcinoma tissue array
with kidney tissue, including pathology grade, TNM, clinical stage , 80
cases/80 cores
|
|
413
|
UKN811
|
8
|
10
|
40
|
80
|
Kidney
|
Kidney cancer and kidney tissue array, including pathology
grade, TNM and clinical stage, 40 cases/80 cores
|
|
414
|
UKN901
|
9
|
10
|
40
|
90
|
Kidney
|
Kidney cancer tissue array with matched adjacent normal kidney
tissue, including pathology grade, TNM and clinical stage, 40 cases/90 cores
|
|
415
|
UNK801
|
8
|
10
|
40
|
80
|
Kidney
|
Kidney cancer tissue array, matched tumor and adjacent normal
tissue
|
|
416
|
LYA501a
|
6
|
9
|
50
|
50
|
Larynx
|
Larynx and pharynx squamous cell carcinoma and normal tissue
array, including pathology grade, TNM and clinical stage, 50 cases/50 cores
|
|
417
|
BC03114 (LV804)
|
8
|
10
|
38
|
80
|
Liver
|
Liver cancer with liver tissue array, including pathology grade,
TNM and clinical stage, 38 cases/80cores, replacing BS03011
|
|
418
|
DCH1001
|
10
|
10
|
50
|
100
|
Liver
|
Gallbladder cancer tissue array with adjacent normal tissue,
including pathology grade, TNM and clinical stage, 50 cases/100 cores
|
|
419
|
DCH901
|
9
|
10
|
75
|
75
|
Liver
|
Gallbladder cancer with adjacent normal tissue array, including
pathology grade, TNM and clinical stage, 45 cases/90 cores
|
|
420
|
DGA2081
|
13
|
16
|
104
|
208
|
Liver
|
Gallbladder disease spectrum (cholecystic cancer progression)
tissue array, including pathology grade, TNM and clinical stage, 104
cases/208 cores
|
|
421
|
DGA461
|
6
|
8
|
20
|
46
|
Liver
|
Gallbladder cancer with matched cancer adjacent tissue array,
including pathology grade, TNM and clinical stage, 20 cases/46 cores
|
| | |